resveratrol and nad
resveratrol has been researched along with nad in 57 studies
Research
Studies (57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (29.82) | 29.6817 |
| 2010's | 34 (59.65) | 24.3611 |
| 2020's | 6 (10.53) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kitson, KE; Kitson, TM; Moore, SA | 1 |
| Bernhard, D; Crazzolara, R; Csordas, A; Kofler, R; Schwaiger, W; Tinhofer, I | 1 |
| Finkel, T | 1 |
| Couzin, J | 1 |
| Araki, T; Milbrandt, J; Sasaki, Y | 1 |
| Guarente, L; Sinclair, DA | 1 |
| Akar, F; Coskun, B; Fehmi Katircioglu, S; Parlar, AI; Soylemez, S; Tulga Ulus, A | 1 |
| Adalbert, R; Asress, S; Beirowski, B; Bridge, K; Coleman, MP; Conforti, L; Fang, G; Glass, JD; Huang, XP; Magni, G; Silva, A; Sorci, L; Wang, MS | 1 |
| Cai, AL; Sheline, CT; Zipfel, GJ | 1 |
| Chen, M; Gupta, M; Gupta, MP; Pillai, JB; Pillai, VB; Rajamohan, SB; Samant, S | 1 |
| Gharavi, R; Gleichmann, M; Liu, D; Mattson, MP; Pitta, M | 1 |
| Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Chaudhary, N; Pfluger, PT | 1 |
| Wu, MR; Xu, F; Zhang, HS; Zhou, HS; Zhou, Y | 1 |
| Chen, K; Chen, L; Feng, Y; Jiang, H; Liu, D; Luo, C; Shen, X; Wu, J | 1 |
| Wu, MR; Zhang, HS | 1 |
| Akar, F; Sepici, A; Soylemez, S | 1 |
| Jung, M; Schemies, J; Sippl, W; Uciechowska, U | 1 |
| Baur, JA | 1 |
| Chen, K; Chen, L; Feng, Y; Jiang, H; Liu, D; Shen, X; Zhou, Y; Zhu, W | 1 |
| Chung, JH; Foretz, M; Kang, H; Kim, MK; McBurney, MW; Park, SJ; Um, JH; Viollet, B; Yang, S | 1 |
| Fivecoat, H; Ho, L; Ling, E; Pan, Y; Pasinetti, GM; Wang, J | 1 |
| Tang, BL | 1 |
| Horio, Y; Houkin, K; Kuno, A; Maruyama, M; Sugino, T; Tanno, M | 1 |
| Liu, W; Sang, WW; Wang, YO; Zhang, HS | 1 |
| Baniahmad, A; Kyrylenko, S | 1 |
| Chandra, G; Mukherjee, AB; Peng, S; Quezado, Z; Saha, A; Wei, H; Zhang, Z | 1 |
| Adachi, T; Amo, T; Fukuda, K; Ishiwata, K; Katsumata, Y; Nakashima-Kamimura, N; Ohta, S; Sano, M; Shinmura, K; Suematsu, M; Tamaki, K; Wolf, AM | 1 |
| Bogo, MR; Bonan, CD; Pereira, TC; Rico, EP; Rosemberg, DB; Schirmer, H; Souto, AA | 1 |
| Daniels, KG; Dearmond, PD; Fitzgerald, MC; Strickland, EC; Xu, Y | 1 |
| Ahmad, F; Baar, K; Beaven, MA; Brown, AL; Burgin, AB; Chung, JH; Ke, H; Kim, MK; Luo, H; Manganiello, V; Park, SJ; Philp, A; Rehmann, H; Taussig, R; Williams, T | 1 |
| Auwerx, J; Houtkooper, RH; Pirinen, E | 1 |
| Camacho-Pereira, J; Chini, CC; Chini, EN; Escande, C; Giri, S; Lou, Z; Matalonga, J; Nin, V | 1 |
| Agarwal, B; Baur, JA; Coppari, R; Davis, JG; de Cabo, R; Duarte, FV; Gomes, AP; Hafner, A; Hubbard, BP; Ling, AJ; Martin-Montalvo, A; Moaddel, R; North, BJ; Palmeira, CM; Price, NL; Ramadori, G; Rolo, AP; Sinclair, DA; Teodoro, JS; Varamini, B; Varela, AT; Ye, L | 1 |
| Allard, C; Codocedo, JF; Godoy, JA; Inestrosa, NC; Varela-Nallar, L | 1 |
| Barber, PA; Chen, ZY; Cui, M; Luo, WJ; Wang, LM; Wang, XJ; Wang, YJ | 1 |
| Ahmad, V; Bever, CT; Chandrasekaran, K; Judge, SI; Makar, TK; Nagalla, NK; Nimmagadda, VK; Royal, W; Russell, JW; Talat, S; Trisler, D; Vattikunta, NR | 1 |
| Brugg, B; Deleglise, B; Duplus, E; Kilinc, D; Magnifico, S; Miquel, MC; Peyrin, JM; Saias, L; Viovy, JL | 1 |
| Alleaume-Butaux, A; Brugg, B; Deleglise, B; Hjorth, JJ; Lassus, B; Peyrin, JM; Schneider, B; Soubeyre, V; Vignes, M; Viovy, JL | 1 |
| Ayer, A; Baron, S; Bonneau, D; Chevrollier, A; Chupin, S; Desquiret-Dumas, V; Ferré, M; Gueguen, N; Henrion, D; Leman, G; Nivet-Antoine, V; Procaccio, V; Reynier, P; Vessières, E | 1 |
| Bobba, N; Calliari, A; Chini, EN; Escande, C | 1 |
| Bruckbauer, A; Zemel, MB | 1 |
| Annese, T; Bonifati, V; Capitanio, N; Cocco, T; De Mari, M; Dell'aquila, C; Di Paola, M; Ferranini, E; Ferretta, A; Gaballo, A; Nico, B; Pacelli, C; Piccoli, C; Tanzarella, P | 1 |
| Cohan, CH; Morris-Blanco, KC; Neumann, JT; Perez-Pinzon, MA; Sick, TJ | 1 |
| Ding, W; Luo, Y; Shao, H; Xue, Q; Yu, B; Zhang, F; Zhang, H; Zhang, X; Zhu, H | 1 |
| Albiero, M; Avogaro, A; Bova, S; Cattelan, A; Ceolotto, G; de Kreutzenberg, SV; De Martin, S; Fadini, GP; Kuppusamy, M; Semplicini, A | 1 |
| Ayer, A; Baron, S; Chupin, S; Desquiret-Dumas, V; Gueguen, N; Henrion, D; Leman, G; Lenaers, G; Nivet-Antoine, V; Procaccio, V; Reynier, P; Vessières, E | 1 |
| Bonkowski, MS; Sinclair, DA | 1 |
| Deng, KY; Guan, XH; Hu, L; Huang, CC; Qian, YS; Wang, LF; Wang, XN; Xiao, YF; Xin, HB | 1 |
| Klimova, B; Kuca, K; Novotny, M | 1 |
| de Medina, P | 1 |
| Cheng, K; Li, S; Song, Z; Wang, T; Zhang, H; Zhang, L | 1 |
| Gong, Z; Jiao, F | 1 |
| Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J | 1 |
| Amatore, C; Huang, WH; Jiang, H; Jiao, YT; Kang, YR; Qi, YT; Wen, MY; Wu, WT; Yang, XK; Zhang, XW | 1 |
| DiNicolantonio, JJ; McCarty, MF; O'Keefe, JH | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
Reviews
11 review(s) available for resveratrol and nad
| Article | Year |
|---|---|
Metabolic benefits from Sirt1 and Sirt1 activators.
Topics: AMP-Activated Protein Kinases; Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Energy Metabolism; Humans; Mice; Mice, Transgenic; NAD; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription, Genetic | 2009 |
NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
Topics: Animals; Epigenesis, Genetic; HIV Infections; Humans; Inhibitory Concentration 50; Models, Chemical; NAD; Neoplasms; Niacinamide; Protein Binding; Resveratrol; Signal Transduction; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 2; Sirtuins; Stilbenes | 2010 |
Biochemical effects of SIRT1 activators.
Topics: Animals; Cardiotonic Agents; Energy Metabolism; Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin Resistance; Learning; Longevity; Memory; Mice; Models, Biological; NAD; Neoplasms; Niacinamide; O-Acetyl-ADP-Ribose; Resveratrol; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 1; Stilbenes | 2010 |
The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Caloric Restriction; Humans; Longevity; NAD; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Sirtuin family: a link to metabolic signaling and senescence.
Topics: Aging; Anti-Inflammatory Agents, Non-Steroidal; Humans; NAD; Resveratrol; Signal Transduction; Sirtuins; Stilbenes | 2010 |
Sirtuins as regulators of metabolism and healthspan.
Topics: Aging; Animals; Energy Metabolism; Glucose; Histones; Homeostasis; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Longevity; Multigene Family; NAD; Phylogeny; Protein Processing, Post-Translational; Resveratrol; Sirtuins; Stilbenes | 2012 |
Slowing ageing by design: the rise of NAD
Topics: Aging; Allosteric Regulation; Animals; Clinical Trials as Topic; Enzyme Activators; Humans; NAD; Resveratrol; Sirtuins; Stilbenes | 2016 |
Anti-Aging Drugs - Prospect of Longer Life?
Topics: Animals; Humans; Longevity; Metformin; NAD; Quality of Life; Resveratrol; Sirolimus; Stilbenes | 2018 |
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.
Topics: Animals; Brain Injuries, Traumatic; Humans; NAD; Neurodegenerative Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Sirtuin 1; Toll-Like Receptors | 2020 |
Nutraceutical activation of Sirt1: a review.
Topics: AMP-Activated Protein Kinases; Dietary Supplements; Humans; NAD; Resveratrol; Sirtuin 1 | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Trials
1 trial(s) available for resveratrol and nad
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Other Studies
46 other study(ies) available for resveratrol and nad
| Article | Year |
|---|---|
Interaction of sheep liver cytosolic aldehyde dehydrogenase with quercetin, resveratrol and diethylstilbestrol.
Topics: Aldehyde Dehydrogenase; Animals; Binding Sites; Catalytic Domain; Cytosol; Diethylstilbestrol; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Kinetics; Liver; Models, Molecular; NAD; Protein Conformation; Quercetin; Resveratrol; Sheep; Stilbenes | 2001 |
Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells.
Topics: Antioxidants; Apoptosis; Artifacts; Cell Division; Colorimetry; Dose-Response Relationship, Drug; Electron Transport; Formazans; Growth Inhibitors; Histocytochemistry; Humans; Indicators and Reagents; Leukemia, T-Cell; Mitochondria; NAD; NADP; Organ Specificity; Oxidation-Reduction; Resveratrol; Stilbenes; Subcellular Fractions; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Ageing: a toast to long life.
Topics: Acetylation; Animals; Caloric Restriction; Flavonoids; Histone Deacetylases; Humans; Longevity; NAD; Phenols; Polymers; Polyphenols; Resveratrol; Saccharomyces cerevisiae; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 1; Sirtuin 2; Sirtuins; Stilbenes; Wine | 2003 |
Scientific community. Aging research's family feud.
Topics: Aging; Animals; Australia; Biotechnology; Caloric Restriction; Histone Deacetylases; History, 20th Century; History, 21st Century; Humans; Longevity; NAD; Niacinamide; Nicotinamidase; Resveratrol; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 2; Sirtuins; Stilbenes; United States | 2004 |
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Topics: 3T3 Cells; Animals; Axons; Axotomy; Benzamides; Cell Line; Cell Nucleus; Cell Survival; Cells, Cultured; Ganglia, Spinal; Humans; Lentivirus; Mice; Mutation; NAD; Naphthols; Nerve Tissue Proteins; Neuroprotective Agents; Nicotinamide-Nucleotide Adenylyltransferase; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Resveratrol; RNA, Small Interfering; Sirtuin 1; Sirtuins; Stilbenes; Ubiquitin-Protein Ligases; Vincristine; Wallerian Degeneration | 2004 |
Unlocking the secrets of longevity genes.
Topics: Aging; Animals; Diet; DNA, Ribosomal; Energy Intake; Energy Metabolism; Humans; Insulin; Insulin-Like Growth Factor I; Longevity; Mutation; NAD; Repetitive Sequences, Nucleic Acid; Resveratrol; Saccharomyces cerevisiae; Sirtuins; Stilbenes; Stress, Physiological | 2006 |
Effect of resveratrol on nitrate tolerance in isolated human internal mammary artery.
Topics: Catalase; Drug Tolerance; Endothelium, Vascular; Humans; Hydrogen Peroxide; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; NAD; Nitroglycerin; Resveratrol; Stilbenes; Superoxide Dismutase; Superoxides; Vasodilation | 2006 |
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
Topics: Animals; Axons; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Nerve Tissue Proteins; Nicotinamide-Nucleotide Adenylyltransferase; Point Mutation; Resveratrol; Sciatic Neuropathy; Stilbenes; Wallerian Degeneration | 2007 |
Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway.
Topics: Aldehydes; Animals; Antioxidants; Brain Ischemia; Cells, Cultured; Flavonoids; Flavonols; Ion Channels; Male; Mitochondria; NAD; Naphthalenes; Neural Conduction; Neurotoxicity Syndromes; Neurotoxins; Niacinamide; Pyridines; Rats; Rats, Long-Evans; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Transcriptional Activation; Zinc | 2006 |
Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the alpha-myosin heavy chain expression.
Topics: Animals; Antioxidants; Antithyroid Agents; Blotting, Western; Cardiomegaly; Cell Size; Cells, Cultured; Densitometry; Diet; Enzyme Activation; Fibrosis; Fructose; Male; Mice; Mice, Transgenic; Myocardium; Myosin Heavy Chains; NAD; Nutritional Physiological Phenomena; Propylthiouracil; Resveratrol; RNA; Sirtuin 1; Sirtuins; Stilbenes; Transfection | 2008 |
Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons.
Topics: Animals; Antioxidants; Brain Ischemia; Cell Death; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; NAD; Neurons; Neuroprotective Agents; Neurotoxins; Niacinamide; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2009 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |
Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; HeLa Cells; HIV Long Terminal Repeat; HIV-1; Humans; NAD; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Sirtuins; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation; Virus Replication | 2009 |
A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.
Topics: Catechin; Coumarins; Fluorescent Dyes; NAD; Peptides; Resveratrol; Sirtuin 1; Spectrometry, Fluorescence; Stilbenes | 2009 |
SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Enzyme Activators; Enzyme Inhibitors; Gene Expression Regulation, Viral; Gene Knockdown Techniques; HIV-1; Host-Pathogen Interactions; Humans; NAD; Niacinamide; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation | 2009 |
Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats.
Topics: Acetylcholine; Angiotensin II; Animals; Antioxidants; Endothelium, Vascular; Female; Male; NAD; NADP; Nitric Oxide; Phenylephrine; Rats; Resveratrol; Sex Factors; Stilbenes; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Wine | 2009 |
Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.
Topics: Acetylation; Animals; Binding Sites; Binding, Competitive; Catalysis; Chelating Agents; Edetic Acid; Humans; Kinetics; Mutation; NAD; Protein Binding; Resveratrol; Sirtuin 1; Spectrometry, Fluorescence; Stilbenes; Substrate Specificity; Zinc; Zinc Fingers | 2010 |
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Drug Resistance; Enzyme Inhibitors; Fibroblasts; Glucose Intolerance; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitochondria; Muscle, Skeletal; NAD; Resveratrol; Sirtuin 1; Stilbenes; Weight Loss | 2010 |
Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
Topics: AMP-Activated Protein Kinases; Animals; Brain; Cell Death; Models, Neurological; NAD; Nerve Degeneration; Neurons; Neuroprotective Agents; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2010 |
Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells.
Topics: Animals; Cell Differentiation; Cytoplasm; Immunoblotting; Immunohistochemistry; NAD; Nerve Growth Factors; Neurites; PC12 Cells; Rats; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Topics: Antineoplastic Agents, Phytogenic; beta-Galactosidase; CD4 Antigens; Dose-Response Relationship, Drug; HeLa Cells; HIV Long Terminal Repeat; Humans; Immunoblotting; NAD; Nicotinamide Phosphoribosyltransferase; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation | 2010 |
Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol.
Topics: Animals; Cells, Cultured; Energy Metabolism; Fibroblasts; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Neuronal Ceroid-Lipofuscinoses; Oxidative Stress; Phosphorylation; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Ribosomal Protein S6 Kinases, 90-kDa; Ribosomes; Stilbenes; Thiolester Hydrolases; Up-Regulation | 2011 |
Caloric restriction primes mitochondria for ischemic stress by deacetylating specific mitochondrial proteins of the electron transport chain.
Topics: Acetylation; Animals; Antioxidants; Blotting, Western; Caloric Restriction; Cells, Cultured; Disease Models, Animal; Electron Transport Chain Complex Proteins; Electron Transport Complex III; Humans; Hydrogen Peroxide; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; NADH Dehydrogenase; Niacinamide; Oxidative Stress; Proteomics; Rats; Rats, Inbred F344; Resveratrol; Sirtuins; Stilbenes | 2011 |
Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver.
Topics: Analysis of Variance; Animals; DNA Primers; Gene Expression Profiling; Gene Expression Regulation; Liver; NAD; Nicotinamide Phosphoribosyltransferase; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Sirtuin 3; Stilbenes; Transcription Factors; Zebrafish | 2012 |
Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach.
Topics: Algorithms; Amino Acid Sequence; Antioxidants; Glutamate Dehydrogenase; Hydrogen Peroxide; Methionine; Molecular Sequence Data; NAD; Oxidants; Oxidation-Reduction; Peptide Fragments; Protein Binding; Proteome; Resveratrol; Saccharomyces cerevisiae Proteins; Stilbenes; Tandem Mass Spectrometry; Thermodynamics | 2011 |
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue, White; Aging; AMP-Activated Protein Kinase Kinases; Animals; Caloric Restriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Diet; Glucose Intolerance; Guanine Nucleotide Exchange Factors; Mice; Models, Molecular; Muscle, Skeletal; NAD; Obesity; Protein Kinases; Resveratrol; Rolipram; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
Topics: Acrylamides; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; AMP-Activated Protein Kinases; Animals; Blotting, Western; Carbazoles; Cell Line, Tumor; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; HEK293 Cells; Hep G2 Cells; Humans; Mice; Mice, Knockout; Models, Biological; Mutation; NAD; Niacinamide; Phosphorylation; Piperidines; Resveratrol; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cells, Cultured; Enzyme Activation; Hepatocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Muscle, Skeletal; NAD; Protein Kinases; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
SIRT1 regulates dendritic development in hippocampal neurons.
Topics: Amyloid beta-Peptides; Animals; Cell Survival; Dendrites; Hippocampus; Immunoblotting; NAD; Neurons; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia.
Topics: Age Factors; AMP-Activated Protein Kinases; Animals; Cerebral Cortex; Diet; Energy Metabolism; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; NAD; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2013 |
Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.
Topics: Animals; Apoptosis; Axons; Brain-Derived Neurotrophic Factor; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; NAD; Neurons; Neuroprotective Agents; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2013 |
NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration.
Topics: Animals; Apoptosis; Axons; Caspases; Mice; Microfluidics; NAD; Resveratrol; Sirtuin 3; Stilbenes | 2013 |
Synapto-protective drugs evaluation in reconstructed neuronal network.
Topics: Amides; Amino Acid Chloromethyl Ketones; Animals; Axons; Dendrites; Embryo, Mammalian; Enzyme Inhibitors; Mice; Microfluidics; Microscopy, Fluorescence; Models, Neurological; NAD; Nerve Net; Neurodegenerative Diseases; Primary Cell Culture; Pyridines; Resveratrol; Stilbenes; Synapses | 2013 |
Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells.
Topics: Animals; Electron Transport Complex I; Enzyme Activation; Hep G2 Cells; Hepatocytes; Humans; Mice; Mice, Inbred C57BL; Mitochondria, Liver; NAD; Oxidation-Reduction; Resveratrol; Sirtuin 3; Stilbenes | 2013 |
Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Cells, Cultured; Disease Models, Animal; Ganglia, Spinal; Humans; In Vitro Techniques; Mice; NAD; Neurofilament Proteins; Neurons; Resveratrol; RNA-Binding Proteins; Sciatic Nerve; Sirtuin 1; Stilbenes; Time Factors; Transfection; Wallerian Degeneration | 2014 |
Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Caffeic Acids; Chlorogenic Acid; Ellagic Acid; Fatty Acids; Humans; Leucine; Mice; Muscle Cells; NAD; Oxidation-Reduction; Phosphodiesterase Inhibitors; Polyphenols; Protein Kinase Inhibitors; Resveratrol; Sirtuin 1; Stilbenes; Valerates; Xanthines | 2014 |
Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Cells, Cultured; Female; Fibroblasts; Genetic Predisposition to Disease; Humans; Middle Aged; Mitochondria; NAD; Oxidative Stress; Oxygen Consumption; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors; Ubiquitin-Protein Ligases | 2014 |
Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Cytokines; Enzyme Inhibitors; Ischemic Preconditioning; Mitochondria; NAD; Nicotinamide Phosphoribosyltransferase; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2014 |
Spinal SIRT1 activation attenuates neuropathic pain in mice.
Topics: Animals; Down-Regulation; Hyperalgesia; Male; Mice; Mice, Inbred Strains; NAD; Neuralgia; Niacinamide; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2014 |
NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Binding Sites; Caspase 3; DNA-Binding Proteins; Enzyme Activation; Forkhead Transcription Factors; Glucose; Heat Shock Transcription Factors; Isolated Heart Preparation; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; Nerve Tissue Proteins; Promoter Regions, Genetic; Rats, Inbred WKY; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Time Factors; Transcription Factors | 2015 |
Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice.
Topics: Age Factors; Animals; Binding Sites; Brain; Cell Respiration; Cells, Cultured; Dose-Response Relationship, Drug; Electron Transport Complex I; Gene Expression Regulation, Enzymologic; Humans; Male; Mice; Mitochondria; Models, Molecular; Molecular Docking Simulation; NAD; Oxidative Stress; Resveratrol; Stilbenes | 2015 |
Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Topics: Acrylamides; AMP-Activated Protein Kinases; Animals; Carbazoles; Cell Line; Cytokines; Diet, High-Fat; Enzyme Inhibitors; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Non-alcoholic Fatty Liver Disease; Oleic Acid; Piperidines; Resveratrol; Signal Transduction; Sirtuin 1; Sterol Regulatory Element Binding Protein 1; Stilbenes | 2017 |
Deciphering the metabolic secret of longevity through the analysis of metabolic response to stress on long-lived species.
Topics: Aging; Animals; Homeostasis; Humans; Longevity; Metabolomics; Mice; Models, Theoretical; Mole Rats; NAD; Neoplasms; Oxidative Stress; Rats; Resveratrol; Species Specificity; Spermidine; Stress, Physiological | 2019 |
Effects of Early Resveratrol Intervention on Skeletal Muscle Mitochondrial Function and Redox Status in Neonatal Piglets with or without Intrauterine Growth Retardation.
Topics: Animals; Animals, Newborn; DNA, Mitochondrial; Electron Transport; Energy Metabolism; Fetal Growth Retardation; Gene Expression Regulation; Glycogen; Male; Metabolome; Mitochondria; Muscle, Skeletal; NAD; Organelle Biogenesis; Oxidation-Reduction; Resveratrol; Swine | 2020 |
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2022 |
Dual-channel nanoelectrochemical sensor for monitoring intracellular ROS and NADH kinetic variations of their concentrations.
Topics: Biosensing Techniques; Kinetics; Metal Nanoparticles; NAD; Oxidation-Reduction; Platinum; Reactive Oxygen Species; Resveratrol | 2023 |